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1. Introduction 
The regulation of 1,25-dihydroxycholecalciferol 
(1 ,25(0H)ZD3) production has been the most hotly 
debated question in vitamin D metabolism. Despite 
the controversies of the past few years it is now agreed 
that the regulation of 1,25(OH)*Ds production is 
multifactorial. The available evidence indicates that 
the production of this hormone is influenced by ionic 
and hormonal factors such as calcium [I], phosphate 
[2], parathyroid hormone [3], prolactin [4], sex 
steroids [S], growth hormone [6] and 1,25(OH)aDs 
[7] itself. 
Until recently,experimental approaches to elucidate 
the regulation of vitamin D metabolism have relied 
almost exclusively upon the use of whole animal 
systems. The inherent inability of in vivo approaches 
to differentiate between primary and secondary 
effects makes interpretation of the results not only 
difficult but also inconclusive and therefore contro- 
versial. Secondary changes can be eliminated by 
studies in vitro. We have shown that primary chick 
kidney cell culture is a very sensitive in vitro system 
to study the regulation of vitamin D metabolism [8]. 
Using this system we have been able to show that 
parathyroid hormone acts directly to regulate both 
renal 25-OHDa hydroxylases. 
2. Materials and methods 
Culture medium (Eagle’s minimum essential medium 
with Earle’s salts), foetal calf serum, trypsin, tryptose 
phosphate broth and antibiotic solution (penicillin 
and streptomycin) were purchased from Gibco- 
Biocult, Paisley, Renfrewshire, Scotland. Bovine 
parathyroid hormone (2500 U/mg) was a gift from 
the National Institute for Biological Standards, 
Hampstead. Radiolabelled 25-hydroxy-[26,27-Me-3H) 
cholecalciferol, spec. act. 9 Ci/mmol, was supplied by 
the Radiochemical Centre, Amersham, Bucks. Crys- 
talline synthetic 1,25(OH), D3 was a gift from 
Dr N. T. Pollitt, Roche Products, Welwyn Garden 
City, Herts. 
2 .l . Cell cultures 
Cockerels (3-4 weeks; Rhode Island Red X Light 
Sussex crossbread; Orchard Farm, Great Missenden, 
Bucks) fed on a vitamin D-deficient diet (1.3% 
calcium, 1 .l% phosphorus) from the day of hatching, 
were used to prepare primary kidney cell cultures as 
in [8]. When confluent, the cells were maintained in a 
serum-free medium for at least 24 h before they were 
used for experimental purposes. Some cultures were 
made vitamin D-replete by treatment for 20-22 h with 
10 ng 1 ,25(OH)*D3/ml and were subsequently main- 
tamed in media containing 100 pg 1 ,25(OH)zD3/ml. 
For acute experiments, cells were treated for 1 h 
with parathyroid hormone or the solvent alone, 
while for chronic experiments the cells were exposed 
every 6 h for 24 h to fresh prewarmed medium con- 
taining either parathyroid hormone or the solvent 
alone. Parathyroid hormone was dissolved in 0.001 M 
acetic acid. Enzyme assays, extraction of lipids, 
chromatography on Sephadex LH-20 columns and 
identification of the vitamin D metabolites were 
carried out as in [8]. 
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3. Results 
The ability of this in vitro system to respond to 
1 ,25(OH),D3 enabled us to manipulate the activity 
of the renal liydroxylases in such a way as to produce 
enzyme patterns similar to the in vivo situations. 
Vitamin D-deficient cells had only I ~-hydroxyiase 
activity (table I) and those treated with 1,25(OH),D, 
possessed both lcu- and 24-hydroxylase activities 
Table 1 
Acute (expt I) and long-term (expt II) effects of bPTII OR 
ltu-hydroxylase activity in vitamin D-deficient primary 
chick kidney cell cultures 
PTH No. 1~AHase activity 
(ng/mU est. (pmol 1,2S(OH),D, .flask-’ .h-I) 
--1__ 
Expt 1 
0 S 5.321 
5 5 5.7 i 0.5 
500 5 5.8 2 0.6 
Expt tI 
0 S 3.7 f 0.5 
S 4 3.6 t 0.2 
SO0 4 2.8 z 0.4 
I____ 
In expt i cells were treated for 1 h with PTH. In expt Ii cells 
were exposed every 6 h for 24 h to fresh prewarmed medium 
containing the indicated PTH concentrations 
C 
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Fig.l. Long-term effects of parathyroid hormane on the renal 
Xi-OHD, hydroxyiases in primary chick kidney cell cultures 
treated with 1,2S(OH),D,. Open bars represent 24-h~drox~tas~ 
and cross hatched bars lnr-hydroxylase activity. n = number of 
estimations. Significantly different from appropriate control: 
*p<O.O25;**p<O.OOl;***p<O.O1. 
(tabte 2). Parathyroid hormone had neither acute nor 
long-term effects on I ~-hydroxy~a~e activity in vita- 
min D-deficient cells (table 1). No acute effects of 
parathyroid hormone were observed on either la- or 
24hydroxylase activity in vitamin D-treated cells 
(table 2, expt I). In contrast chronic treatment with 
parathyroid hormone caused a marked inhibition in 
24~hydroxy~ase and a modest but statistically signifi- 
cant stimulation in lol-hydroxylase activity (table 2, 
expt II and fig.1). 
Table 2 
Acute (expt i) and long-term (expt 11) effects of bPTf_l on the renal ‘LS-OHD, 
hydroxylases in primary chick kidney cell cultures treated with 1,2S(OH),D, 
PTH 
(nglml) 
No. 
est. 
Enzyme activity 
(pmol metabolite produced Alask-’ .h-‘1 
24-OHase 1cu-Offase 
Expt I 
0 
5 
500 
4 6.6 f 0.9 3.0 f 0.5 
5 6.5 f 0.5 3.2 r 0.2 
5 5.8 t 0.8 3.1 + 0.5 
Expt fl 
0 5 5.2 * 0.6 2.7 4: 0.4 
5 4 3.0 + 0.4” 4.1 I0.4b 
500 5 I .5 + 0.6d 3.8 t 0.4” 
Significantly different from appropriate control: a p < 0.05; b p < 0.025; 
cp < O.Ol;dp -CO.001 
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4. Discussion 
The realization that 1 ,25(OH)2Da is a very potent 
calcium mobilizing hormone gave impetus to investiga- 
tion of the physiological mechanisms controlling its 
secretion by the kidney. Parathyroid hormone was 
one of the first factors to be implicated in the regula- 
tion of la-hydroxylase, the enzyme responsible for 
the production of 1 ,25(OH)2D3 [3,9]. The evidence 
in favour of a regulatory role of parathyroid hormone 
in 1,25(OH)*Da production stems mainly from 
ablation experiments in vitamin D-replete animals. 
It has been shown in animals fed a low calcium vita- 
min D-supplemented diet, that parathyroidectomy 
suppresses the production of 1 ,25(OH)zD3 and stim- 
ulates the production of 24,25(OH),Da. Administra- 
tion of parathyroid hormone restores those enzyme 
activities to normal, over a period of several hours 
]3,91. 
In contrast in vitamin D-deficient animals,in which 
only la-hydroxylase is present, parathyroid hormone 
has no effect [lo,1 I]. Our findings in vitro are in 
very good agreement with these in vivo observations. 
No acute effects of parathyroid hormones were 
observed in either vitamin D-deficient or vitamin 
D-replete cell cultures. Moreover, chronic treatment 
with this hormone did not affect the lc+hydroxylase 
activity in vitamin D-deficient cells, whereas in vita- 
min D-replete cells it produced a marked suppression 
of 24-hydroxylase and a modest stimulation in 
la-hydroxylase activity. This is to our knowledge the 
first demonstration that parathyroid hormone acts 
directly on the kidney cells to regulate the activities 
of both hydroxylases in a fashion similar to that 
observed in experiments in vivo. Others have also 
reported that chronic treatment with parathyroid 
hormone suppresses the 24-hydroxylase activity in 
primary kidney cell cultures and cell lines from 
mammalian species [ 12,131. It is interesting to note 
that these cells lacked la-hydroxylase activity even 
though they were cultured for several days in the 
absence of any form of vitamin D. 
In 1972 it was claimed that parathyroid hormone 
stimulates acutely the la-hydroxylase activity in 
isolated renal tubules from vitamin D-deficient chicks 
[ 141. This observation not only is difficult to recon- 
cile with in vivo findings, but it has not been repro- 
duced [ 15 ,I 61. The failure to show an effect of chronic 
treatment with parathyroid hormone on the 
lahydroxylase activity in vitamin D-deficient chick 
kidney cell cultures [ 171 is in agreement with our 
observations. 
Our results show that PTH has a more marked 
effect on 24-hydroxylase than on lo-hydroxylase. 
This may be due to the experimental conditions. 
Because we used initially a high concentration of 
1,25(OH)*Da to suppress the la-hydroxylase and to 
induce the 24-hydroxylase, it is possible that para- 
thyroid hormone was able to suppress the 24-hydrox- 
ylase more readily than to overcome the suppressive 
effect of 1,25(OH)*Da on the lo-hydroxylase. 
Such an explanation seems to be supported by the 
in vivo observations [ 181. These authors have shown 
that in vitamin D-deficient chicks treated with a 
single injection of 130 ng 1 ,25(OH)zDa, parathyroid 
hormone suppressed the 24-hydroxylase but had no 
effect on la-hydroxylase activity. An alternative 
explanation may be that the 24-hydroxylase is more 
sensitive to the effects of parathyroid hormone than 
the la-hydroxylase. In either case, the fact remains 
that parathyroid hormone has a profound influence 
on 24-hydroxylase, but the physiological significance 
of this regulatory effect is at present unknown. 
The reason for the failure of PTH to stimulate 
the la-hydroxylase activity in either vitamin D-defi- 
cient animals or cells is unclear. It may be that para- 
thyroid hormone cannot further stimulate the 
la-hydroxylase due to the fact that the activity of 
this enzyme is already very high as a result of vitamin 
D-deficiency. By the same token, it may be argued 
that vitamin D-supplementation by suppressing the 
la-hydroxylase activity, enables the stimulatory effect 
of parathyroid hormone on this enzyme to become 
apparent. Others have suggested that 1,25(OH)*Ds is 
required not only for the appearance of 24-hydroxylase, 
but also to induce a change in the renal cell which in 
turn permits regulation of the hydroxylases by para- 
thyroid hormone [ lo,1 1,191. But, recent work in 
mammalian cell cultures indicates that neither the 
presence of 1 ,25(OH)2D3 nor la-hydroxylase are 
required for parathyroid hormone to regulate the 
24-hydroxylase activity [ 12,131. By contrast studies 
carried out in vivo [3,9] as well as our observations 
in primary chick kidney cell cultures indicate that 
parathyroid hormone stimulates the lo-hydroxylase 
activity only under situations in which both enzymes 
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are present. Therefore, it is conceivable that the 
primary effect of parathyroid hormone may be the 
suppression of 24-hydroxylase leading to greater 
availability of substrate for la-hydroxylase and thus 
to increased production of 1,25(OH),Ds. 
The physiological function of 1 ,25(OH)2Da is 
largely unknown, let alone the regulation of its 
production. It has been suggested that in the bird 
and lower species the 24-hydroxylation developed 
as an inactivation mechanism for vitamin D and 
that 24,25(OH)*Da represents an excretory route 
for vitamin Da [20]. In mammals, 24,25(OH)*Da 
is also less active than l,25(0H)2D3 in terms of 
calcium mobilizing activity [21,22]. However, recent 
studies have led to claims that 24,25(OH)zD3 plays 
a significant role in bone calcification [23,24]. If 
these claims are confirmed, then the demonstration 
that the production of 24,25(OH)2Ds is regulated by 
parathyroid hormone may provide an unsuspected 
insight into the regulation of calcium homeostasis. 
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